Codify — Article

HB 4445 Reauthorizes Public Health and Bio-Preparedness Loan Repayment

Extends the loan repayment program through FY 2026–2030 to sustain recruitment and retention of critical public health and bio-preparedness staff.

The Brief

The bill amends the Public Health Service Act to extend the authorization of the Public Health and Bio-Preparedness Workforce Loan Repayment Program. Specifically, it replaces the current end-date of fiscal years 2023 through 2025 with a new window of fiscal years 2026 through 2030.

This is a straightforward reauthorization rather than a program redesign.

Why it matters: extending the program ensures continued incentives for health professionals to enter and remain in essential public health and bio-preparedness roles. The bill does not introduce new funding levels or eligibility changes in its text, so the policy impact rests on maintaining the existing program structure during the extended period.

Professionals and agencies relying on this mechanism can plan with greater certainty, absent any substantive program changes.

At a Glance

What It Does

Amends Section 776(i) of the Public Health Service Act to replace the authorization window from FY 2023–2025 with FY 2026–2030, effectively extending the loan repayment program.

Who It Affects

Participants and potential participants in the Public Health and Bio-Preparedness Workforce Loan Repayment Program, plus the federal programs and public health departments that administer and oversee the program.

Why It Matters

Preserves a critical workforce incentive during a period of ongoing public health preparedness planning, ensuring continuity for recruitment and retention of needed personnel.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

This measure is a targeted reauthorization. By updating the statutory endpoint for the loan repayment program, it ensures that public health and bio-preparedness staff can continue to receive loan support through 2030.

The structure, scope, and administration of the program remain as authorized by the existing Public Health Service Act provisions; no new eligibility criteria, funding amounts, or programmatic changes are introduced in the text provided. For compliance and implementation teams, the bill means that agencies will continue to administer the existing repayment benefits under the same rules, but with a shifted timeline for when those benefits must be available to qualifying borrowers.

As with prior iterations, the program serves as a tool to attract and retain skilled professionals in high-need public health roles, supporting readiness for public health emergencies and ongoing population health activities.

The Five Things You Need to Know

1

The bill extends the Public Health and Bio-Preparedness Workforce Loan Repayment Program from FY 2023–2025 to FY 2026–2030.

2

It amends Section 776(i) of the Public Health Service Act (42 U.S.C. 295f-1(i)).

3

No new funding levels or program changes are specified in the text beyond the extension.

4

The short title is the Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025.

5

Introduced in the 119th Congress by Rep. Crow and colleagues; referred to the Committee on Energy and Commerce.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short Title

Establishes the bill’s official name as the Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025. This section does not alter program mechanics but provides the formal designation used in law and in agency guidance.

Section 2

Reauthorization of the Loan Repayment Program

Amends Section 776(i) of the Public Health Service Act to replace the current authorization window (FY 2023–2025) with FY 2026–2030. The practical effect is to extend the program’s authorization period, enabling continued loan repayment support for eligible public health and bio-preparedness workers without altering the program’s existing structure, eligibility criteria, or funding approach in the text.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Public health professionals currently enrolled or eligible for the loan repayment program, who can anticipate continued loan relief as they serve in public health or bio-preparedness roles.
  • Public health departments and agencies that rely on loan repayment incentives to recruit and retain staff in high-need positions.
  • Organizations and employers in health systems that regularly partner with the Public Health Service Act program to staff critical public health roles.

Who Bears the Cost

  • Federal government budget allocations to the Public Health Service Act loan repayment program, funded through annual appropriations.
  • Taxpayers who ultimately finance federal loan repayment subsidies through government programs.
  • Public health agencies that administer and oversee the program within their budgeting constraints, should funding levels be adjusted in future appropriations.

Key Issues

The Core Tension

Extending the authorization without explicit funding guarantees creates a classic budgetary trade-off: sustain a proven workforce incentive vs. the risk of funding gaps or pressure to constrain future expansions if appropriations are capped.

The bill’s text is narrowly focused on extending the authorization window for the loan repayment program. It does not specify new funding levels or alter eligibility criteria, which means the policy impact rests on the continued availability of appropriations to finance repayments.

A key tension for implementers is ensuring annual funding remains sufficient to honor existing commitments while not expanding the program beyond its current scope. Administrators will also need to maintain compliance with existing reporting and oversight requirements unless otherwise updated in future amendments.

Core potential questions include whether the extension will necessitate new appropriations cycles, how changes in workforce demand might affect enrollment, and how the extended authorization interacts with broader public health workforce initiatives that may compete for limited federal dollars.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.